FDA Drug Application (018733) for TALWIN NX by SANOFI AVENTIS US

Back to FDA Applications sponsored by SANOFI AVENTIS US

Application Number018733
Product Number001
FormTABLET;ORAL
DosageEQ 0.5MG BASE;EQ 50MG BASE
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameTALWIN NX
Active IngredientNALOXONE HYDROCHLORIDE; PENTAZOCINE HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient NALOXONE HYDROCHLORIDE12
List of drugs with Active Ingredient PENTAZOCINE HYDROCHLORIDE6


Back to FDA Applications sponsored by SANOFI AVENTIS US